ZEPP HEALTH CORP-ADR (ZEPP)
US98945L1052 - ADR
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 928.20M | 886.60M | 1.47B | 2.28B | 1.80B | |||
| Marketable Securities | 24.60M | 34.30M | 19.40M | 18.40M | 17.20M | |||
| Receivables | 578.90M | 870.30M | 1.09B | 1.28B | 1.66B | |||
| Inventories | 787.00M | 1.02B | 1.25B | 1.22B | 893.80M | |||
| Other Current Assets | 185.60M | 145.30M | 100.90M | 33.50M | 14.40M | |||
| Total Current Assets | 2.50B | 2.96B | 3.93B | 4.83B | 4.39B | |||
| Non-Current Assets | ||||||||
| PPE Net | 111.60M | 166.20M | 242.30M | 275.80M | 173.00M | |||
| Investments And Advances | 1.70B | 1.69B | 1.55B | 444.00M | 406.10M | |||
| Goodwill | 69.90M | 66.10M | 61.10M | 62.50M | 5.90M | |||
| Intangibles | 104.90M | 123.30M | 135.60M | 145.20M | 85.80M | |||
| Other Non-Current Assets | 339.20M | 260.60M | 163.00M | 148.40M | 111.50M | |||
| Total Non-Current Assets | 2.33B | 2.31B | 2.15B | 1.08B | 782.20M | |||
| TOTAL ASSETS | 4.83B | 5.27B | 6.09B | 5.90B | 5.17B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 566.40M | 968.40M | 461.80M | 504.70M | 2.20M | |||
| Current Portion Of LT Debt. | N/A | 42.32M | 50.09M | N/A | N/A | |||
| Accrued Expenses | 152.60M | 92.60M | 139.70M | 134.70M | 256.10M | |||
| Accounts Payable | 479.80M | 497.60M | 1.37B | 1.96B | 2.01B | |||
| Other Current Liabilities | 23.90M | 110.00M | 183.20M | 187.80M | 208.80M | |||
| Total Current Liabilities | 1.22B | 1.67B | 2.15B | 2.79B | 2.48B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 861.40M | 684.20M | 726.90M | 60.00M | 0.00 | |||
| Deferred Taxes/Income | 33.70M | 35.60M | 26.90M | 22.40M | 5.40M | |||
| Other Non-Current Liabilities | 179.50M | 194.30M | 246.20M | 301.40M | 190.00M | |||
| Total Non-Current Liabilities | 1.09B | 926.40M | 1.01B | 383.80M | 192.20M | |||
| TOTAL LIABILITIES | 2.31B | 2.60B | 3.17B | 3.17B | 2.67B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 739.20M | 942.80M | 1.27B | 1.13B | 910.60M | |||
| Additional Paid In Capital | 1.74B | 1.69B | 1.64B | 1.55B | 1.48B | |||
| Minority Interest | 12.00M | 13.10M | 14.00M | -1.00M | -1.40M | |||
| Common Shares | 200.00K | 200.00K | 200.00K | 200.00K | 200.00K | |||
| Treasury Stock | -81.40M | -67.20M | -21.80M | N/A | N/A | |||
| Other Shareholders' Equity | 127.60M | 105.80M | 29.30M | 44.60M | 111.10M | |||
| Shares Outstanding | 57.19M | 58.83M | 58.83M | 58.57M | 57.97M | |||
| Tangible Book Value per Share | 9.62 | 9.88 | 10.84 | 10.09 | 9.73 | |||
| Total Shareholders' Equity | 2.52B | 2.67B | 2.92B | 2.73B | 2.50B | |||
| TOTAL LIABILITIES AND EQUITY | 4.83B | 5.27B | 6.09B | 5.90B | 5.17B | |||
| Statistics | ||||||||
| Debt/Equity | 0.57 | 0.62 | 0.41 | 0.21 | N/A | |||
| Current Ratio | 2.05 | 1.77 | 1.83 | 1.73 | 1.77 | |||
| Return On Assets (ROA) | -5.77% | -5.47% | 2.26% | 3.88% | 11.07% | |||
| Return On Equity (ROE) | -11.06% | -10.79% | 4.72% | 8.38% | 22.90% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 1.69% | 3.80% | 17.78% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 2.56% | 10.41% | 54.77% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 2.74% | 12.35% | 61.18% | |||
All data in CNY